Page last updated: 2024-11-12

zabofloxacin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

zabofloxacin: a fluoroquinolone antibiotic [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10388396
CHEMBL ID2107811
SCHEMBL ID2985495
MeSH IDM0458482

Synonyms (12)

Synonym
dw-224a
zabofloxacin
219680-11-2
CHEMBL2107811
zabofloxacin [who-dd]
SCHEMBL2985495
1-cyclopropyl-6-fluoro-7-[(8z)-8-methoxyimino-2,6-diazaspiro[3.4]octan-6-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid
Q17143544
CS-0025745
HY-106410
gtpl10873
AKOS040740615

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The absolute toxic dose of DW-224a was 30 mg/kg and the level at which no adverse effects were observed was 10 mg/kg for both sexes."( Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs.
Choi, DR; Chung, MK; Han, J; Kim, B; Kim, JC, 2003
)
0.32
" Our data suggested that DW-224a showed no adverse effects on the central nervous system, cardiovascular system, and respiratory system, with the exception of the effect on the QT interval prolongation."( Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent.
Han, SS; Kim, EJ; Kim, KS; Shin, WH, 2004
)
0.32

Pharmacokinetics

The applicability of the developed assay method to pharmacokinetic studies of zabofloxacin in rats was examined.

ExcerptReferenceRelevance
" The method described in the present study is applicable to routine pharmacokinetic studies in rats."( Determination of zabofloxacin in rat plasma by liquid chromatography with mass spectrometry and its application to pharmacokinetic study.
Chung, SJ; Jin, HE; Kang, IH; Lee, KR; Shim, CK, 2011
)
0.71
"To develop an HPLC method using fluorescence detection for the pharmacokinetic evaluation of levels of zabofloxacin, a novel broad spectrum fluoroquinolone antibiotic, in the plasma, bile and urine of rats."( Fluorescence detection of Zabofloxacin, a novel fluoroquinolone antibiotic, in plasma, bile, and urine by HPLC: the first oral and intravenous applications in a pharmacokinetic study in rats.
Jin, HE; Kang, IH; Shim, CK, 2011
)
0.88
" The applicability of the developed assay method to pharmacokinetic studies of zabofloxacin in rats was examined."( Fluorescence detection of Zabofloxacin, a novel fluoroquinolone antibiotic, in plasma, bile, and urine by HPLC: the first oral and intravenous applications in a pharmacokinetic study in rats.
Jin, HE; Kang, IH; Shim, CK, 2011
)
0.9
"These observations suggest that a validated assay can be used in pharmacokinetic studies of zabofloxacin in small animals."( Fluorescence detection of Zabofloxacin, a novel fluoroquinolone antibiotic, in plasma, bile, and urine by HPLC: the first oral and intravenous applications in a pharmacokinetic study in rats.
Jin, HE; Kang, IH; Shim, CK, 2011
)
0.89
" This review focuses on recent advances concerning quinolones and fluoroquinolones, we will be summarising chemical structure, mode of action, pharmacokinetic properties and toxicity."( Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
Domokos, J; Kocsis, B; Szabo, D, 2016
)
0.64

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of zabofloxacin was 27."( Fluorescence detection of Zabofloxacin, a novel fluoroquinolone antibiotic, in plasma, bile, and urine by HPLC: the first oral and intravenous applications in a pharmacokinetic study in rats.
Jin, HE; Kang, IH; Shim, CK, 2011
)
0.98

Dosage Studied

ExcerptRelevanceReference
" The maximum plasma concentrations (Cmax), the area under the plasma concentration versus time curve (AUC) from the time of dosing to 48 hours post-dosing (AUClast), and the AUC extrapolated to infinity (AUCinf) were determined from the plasma concentration-time profile."( Comparison of pharmacokinetics between new quinolone antibiotics: the zabofloxacin hydrochloride capsule and the zabofloxacin aspartate tablet.
Cho, JY; Han, H; Kim, SE; Lim, C; Lim, KS; Shin, KH; Yu, KS, 2013
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (46.67)29.6817
2010's7 (46.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.88 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (18.75%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]